M. Cheng

发表

The acute effects of azithromycin use on cardiovascular mortality as compared with amoxicillin–clavulanate in US Veterans

A. Anzueto, Y. Young-Xu, M. Duh, 2022, Pharmacoepidemiology and drug safety.

Correlation of BCL-2 and ERα mRNA Expression with the Clinical Chemotherapeutic Response in Breast Cancer

Y. Chao, Hung‐Shang Tang, Chung‐Te Hsu, 2017 .

Profiling Disease and Economic Burden in CRSwNP Using Machine Learning

N. Bhattacharyya, M. Duh, W. Cheng, 2022, Journal of asthma and allergy.

Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study

D. Metz, P. Lapuerta, V. Joish, 2020, Cancer management and research.

CMAR_A_261257 6607..6614

D. Metz, P. Lapuerta, V. Joish, 2020 .

Preoperative Lanreotide Treatment Improves Outcome in Patients with Acromegaly Resulting from Invasive Pituitary Macroadenoma

Z. Quan, M. Cheng, Z-Q Li, 2012, The Journal of international medical research.

P2.01-103 Real-World Treatment Patterns and Survival in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations

S. Ou, M. Duh, R. Bhak, 2019, Journal of Thoracic Oncology.

Treatment of metastatic castration resistant prostate cancer with radium-223: a retrospective study at a US tertiary oncology center

M. Taplin, R. McKay, M. Duh, 2020, Prostate Cancer and Prostatic Diseases.

Real-World Treatment Patterns and Physician Preferences for Biologics in Moderate-to-Severe Inflammatory Bowel Disease: Retrospective Chart Review in Europe

S. Hass, L. Peyrin-Biroulet, M. Duh, 2022, Crohn's & colitis 360.

Suicidal ideation and attempts in the United States of America among stimulant-treated, non-stimulant-treated, and untreated patients with a diagnosis of attention-deficit/hyperactivity disorder.

C. Siffel, M. Duh, W. Spalding, 2020, Journal of affective disorders.

Network meta-analysis of efficacy of ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma

D. Cherepanov, M. Duh, R. Bhak, 2023, Hematology.

Analysis of Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine Tumors.

M. Kim, M. Duh, L. Huynh, 2019, Pancreas.

Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records data.

D. Cherepanov, M. Duh, L. Sanchez, 2024, Current problems in cancer.

Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program.

Y. Young-Xu, W. Garvey, M. Duh, 2023, Population health management.

Health care costs among patients with relapsed/refractory multiple myeloma treated with ixazomib or daratumumab in combination with lenalidomide and dexamethasone in the United States

M. Duh, M. Cheng, S. Ailawadhi, 2024, Journal of Managed Care & Specialty Pharmacy.

Comparison of health care costs and resource utilization for commonly used proteasome inhibitor-immunomodulatory drug-based triplet regimens for the management of patients with relapsed/refractory multiple myeloma in the United States.

D. Cherepanov, A. Chari, M. Duh, 2023, Journal of managed care & specialty pharmacy.